Erwin Schollmayer

1.3k citations
27 papers · 955 · h-index 15

Impact in

  • Neurology top 2%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
  • Epidemiology top 2%
    • Restless Legs Syndrome Research

Papers in

  • Epidemiology 24
    • Restless Legs Syndrome Research 24
  • Neurology 8
    • Parkinson's Disease Mechanisms and Treatments 8
    • Parkinson's Disease and Spinal Disorders 2
    • Neurological disorders and treatments 1
Co-authors
Ralf Kohnen (9 shared papers)Wolfgang H. Oertel (10 shared papers)Karin Stiasny‐Kolster (8 shared papers)Heike Beneš (12 shared papers)Claudia Trenkwalder (12 shared papers)Diego Garcı́a-Borreguero (9 shared papers)Birgit Högl (8 shared papers)Luigi Ferini‐Strambi (5 shared papers)
Journals
Sleep Medicine (12 papers)Neurology (3 papers)American Journal of Therapeutics (3 papers)Movement Disorders (2 papers)BMC Neurology (2 papers)
Partner nations
GermanyUnited StatesAustria

In The Last Decade

Erwin Schollmayer

27 papers receiving 926 citations

Peers

Erwin Schollmayer
Comparison fields: 5 of 34
  • Neurology 546
  • Epidemiology 779
  • Cognitive Neuroscience 401
  • Biological Psychiatry 15
  • Nephrology 43
Replace Ayaka Numao with:
Ayaka Numao Japan
Frank Grieger Germany
Denise Sharon United States
Greg Kearns United States
Maria Ossola Italy
Chuanzhu Sun China
Stephen Thein United States
David Winslow United States
Xiong‐Fei Xie China
Mitsuru Shiba Japan
Erwin Schollmayer relative to Ayaka Numao Japan Ayaka Numao's profile →
Citations per field
00.5×5×10×15×
Ayaka Numao · 1×
Citations per year

Countries citing papers authored by Erwin Schollmayer

Since Specialization
Citations

This map shows the geographic impact of Erwin Schollmayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Schollmayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Schollmayer more than expected).

Fields of papers citing papers by Erwin Schollmayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Schollmayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Schollmayer. The network helps show where Erwin Schollmayer may publish in the future.

Co-authors

The 25 scholars most cited alongside Erwin Schollmayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erwin Schollmayer Line = papers co-authored together Erwin Schollmayer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial
The Lancet Neurology ·Claudia Trenkwalder, Heike Beneš, Werner Poewe, Wolfgang H. Oertel, Diego Garcı́a-Borreguero, Al W. de Weerd, Luigi Ferini‐Strambi, Pasquale Montagna, Per Odin, Karin Stiasny‐Kolster, Birgit Högl, К. Ray Chaudhuri, Markku Partinen, Erwin Schollmayer, Ralf Kohnen
2008154
2
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double‐blind, placebo‐controlled pilot study
Movement Disorders ·Karin Stiasny‐Kolster, Ralf Kohnen, Erwin Schollmayer, Jens Carsten Möller, Wolfgang H. Oertel, (unknown)
2004108
3
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
The Lancet Neurology ·Wolfgang H. Oertel, Claudia Trenkwalder, Heike Beneš, Luigi Ferini‐Strambi, Birgit Högl, Werner Poewe, Karin Stiasny‐Kolster, Andreas Fichtner, Erwin Schollmayer, Ralf Kohnen, Diego Garcı́a-Borreguero
201199
4
Rotigotine improves restless legs syndrome: A 6‐month randomized, double‐blind, placebo‐controlled trial in the United States
Movement Disorders ·Wayne A. Hening, Richard P. Allen, William G. Ondo, Arthur S. Walters, John W. Winkelman, Philip M. Becker, Richard Bogan, June M. Fry, David Kudrow, Kurt W. Lesh, Andreas Fichtner, Erwin Schollmayer, (unknown)
201087
5
Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
Sleep Medicine ·Wolfgang H. Oertel, Heike Beneš, Diego Garcı́a-Borreguero, Peter Geisler, Birgit Högl, B. Saletu, Claudia Trenkwalder, Kenneth W. Sommerville, Erwin Schollmayer, Ralf Kohnen, Karin Stiasny‐Kolster
200782
6
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study
Sleep Medicine ·Wolfgang H. Oertel, Heike Beneš, Diego Garcı́a-Borreguero, Birgit Högl, Werner Poewe, Pasquale Montagna, Luigi Ferini‐Strambi, Friederike Sixel‐Döring, Claudia Trenkwalder, Markku Partinen, B. Saletu, Olli Polo, Andreas Fichtner, Erwin Schollmayer, Ralf Kohnen, Werner Cassel, Thomas Penzel, Karin Stiasny‐Kolster
201077
7
Prevention of Contrast Media-Induced Renal Dysfunction With Prostaglandin E 1 : A Randomized, Double-Blind, Placebo-Controlled Study
American Journal of Therapeutics ·Michael H. Sketch, Andrew Whelton, Erwin Schollmayer, Jens Albrecht Koch, P. Bernink, Franz Woltering, Jeffrey Brinker
200151
8
One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome
Sleep Medicine ·Wolfgang H. Oertel, Heike Beneš, Diego Garcı́a-Borreguero, Peter Geisler, Birgit Högl, Claudia Trenkwalder, I. Tacken, Erwin Schollmayer, Ralf Kohnen, Karin Stiasny‐Kolster
200843
9
Significant association between systolic and diastolic blood pressure elevations and periodic limb movements in patients with idiopathic restless legs syndrome
Sleep Medicine ·Werner Cassel, Karl Kesper, Axel Bauer, Frank Grieger, Erwin Schollmayer, Lars Joeres, Claudia Trenkwalder
201543
10
Augmentation in the treatment of restless legs syndrome with transdermal rotigotine
Sleep Medicine ·Heike Beneš, Diego Garcı́a-Borreguero, Luigi Ferini‐Strambi, Erwin Schollmayer, Andreas Fichtner, Ralf Kohnen
201234
11
Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial
American Journal of Kidney Diseases ·Yves Dauvilliers, Heike Beneš, Markku Partinen, Virpi Rauta, Daniel Rifkin, Elisabeth Dohin, Nadine Goldammer, Erwin Schollmayer, Hanna Schröder, John W. Winkelman
201633
12
Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch
BMC Neurology ·Birgit Högl, Wolfgang H. Oertel, Karin Stiasny‐Kolster, Peter Geisler, Heike Beneš, Diego Garcı́a-Borreguero, Claudia Trenkwalder, Werner Poewe, Erwin Schollmayer, Ralf Kohnen
201031
13
Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire
Sleep Medicine ·Richard P. Allen, Wolfgang H. Oertel, Arthur S. Walters, Heike Beneš, Erwin Schollmayer, Frank Grieger, Kimberly Moran, Ralf Kohnen
201322
14
Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study
Sleep Medicine ·Claudia Trenkwalder, Monica Canelo, Michael Lang, Hanna Schroeder, Daniela Kelling, Reinhard Berkels, Erwin Schollmayer, Tanja Heidbrede, Heike Beneš
201519
15
Pharmacokinetics of rotigotine transdermal system in adolescents with idiopathic restless legs syndrome (Willis–Ekbom disease)
Sleep Medicine ·Jan‐Peer Elshoff, J Douglas Hudson, Daniel L. Picchietti, Keith R. Ridel, Arthur S. Walters, Kimberly Doggett, Kimberly Moran, Marga Oortgiesen, Francisco C. Ramirez, Erwin Schollmayer
201615
16
Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study
Current Medical Research and Opinion ·Diego Garcı́a-Borreguero, Richard P. Allen, J Douglas Hudson, Elisabeth Dohin, Frank Grieger, Kimberly Moran, Erwin Schollmayer, René Smit, John W. Winkelman
201513
17
Transdermal rotigotine for the perioperative management of restless legs syndrome
BMC Neurology ·Birgit Högl, Wolfgang H. Oertel, Erwin Schollmayer, Lars Bauer
201212
18
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany
Sleep Medicine ·Karin Stiasny‐Kolster, Daniela Berg, Werner Hofmann, Reinhard Berkels, Frank Grieger, Thomas Lauterbach, Erwin Schollmayer, Cornelius G. Bachmann
201311
19
Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: apost-hocanalysis of patients taking 1 – 3 mg/24 h for up to 5 years
Expert Opinion on Pharmacotherapy ·Elisabeth Dohin, Birgit Högl, Luigi Ferini‐Strambi, Erwin Schollmayer, Andreas Fichtner, Lars Bauer, Diego Garcı́a-Borreguero
201210
20
Rotigotine in Patients with Restless Legs Syndrome and End-stage Renal Disease Requiring Hemodialysis (P7.298)
Neurology ·John W. Winkelman, Yves Dauvilliers, Markku Partinen, Heike Beneš, Virpi Rauta, Hanna Schröder, Nadine Goldammer, Elisabeth Dohin, Erwin Schollmayer
20152

About Erwin Schollmayer

Erwin Schollmayer is a scholar working on Epidemiology, Neurology, Cognitive Neuroscience, Cardiology and Cardiovascular Medicine and Nephrology, having authored 27 papers that have together received 955 indexed citations. Recurring topics across this work include Restless Legs Syndrome Research (24 papers), Parkinson's Disease Mechanisms and Treatments (8 papers), Sleep and Wakefulness Research (3 papers), Parkinson's Disease and Spinal Disorders (2 papers), Heart Failure Treatment and Management (1 paper), Stuttering Research and Treatment (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Neurological disorders and treatments (1 paper). The work is most often cited by research in Neurology (546 citations), Epidemiology (779 citations), Cognitive Neuroscience (401 citations), Biological Psychiatry (15 citations) and Nephrology (43 citations). Erwin Schollmayer has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Ralf Kohnen, Wolfgang H. Oertel, Karin Stiasny‐Kolster, Heike Beneš, Claudia Trenkwalder, Diego Garcı́a-Borreguero, Birgit Högl, Luigi Ferini‐Strambi, Werner Poewe and Andreas Fichtner. Their work appears in journals such as Sleep Medicine, Neurology, American Journal of Therapeutics, Movement Disorders and BMC Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayaka NumaoBreakdown of academic impact, for papers by Frank GriegerBreakdown of academic impact, for papers by Denise SharonBreakdown of academic impact, for papers by Greg KearnsBreakdown of academic impact, for papers by Maria OssolaBreakdown of academic impact, for papers by Chuanzhu SunBreakdown of academic impact, for papers by Stephen TheinBreakdown of academic impact, for papers by David WinslowBreakdown of academic impact, for papers by Xiong‐Fei XieBreakdown of academic impact, for papers by Mitsuru Shiba